Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lexaria Bioscience Corp 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 CAN

www.lexariabioscience.com Employees: 7 P: 250-765-6424

Sector:

Medical

Description:

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.

Key Statistics

Overview:

Market Capitalization, $K 24,893
Enterprise Value, $K 18,393
Shares Outstanding, K 22,226
Annual Sales, $ 710 K
Annual Net Income, $ -11,900 K
Last Quarter Sales, $ 170 K
Last Quarter Net Income, $ -2,700 K
EBIT, $ -9,190 K
EBITDA, $ -5,670 K
60-Month Beta 0.63
% of Insider Shareholders 26.40%
% of Institutional Shareholders 13.06%
Float, K 16,358
% Float 73.60%
Short Volume Ratio 0.38

Growth:

1-Year Return -56.76%
3-Year Return -61.77%
5-Year Return 0.00%
5-Year Revenue Growth 86.84%
5-Year Earnings Growth 56.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/26/25
Next Earnings Date 01/09/26
Earnings Per Share ttm -0.65
EPS Growth vs. Prev Qtr 38.10%
EPS Growth vs. Prev Year 13.33%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

LEXX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -198.99%
Return-on-Assets % -162.00%
Profit Margin % -1,676.06%
Debt/Equity 0.00
Price/Sales 34.94
Price/Cash Flow N/A
Price/Book 7.96
Book Value/Share 0.29
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar